Clinical trial reportJournal for immunotherapy of cancerPublished
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Penn Medicine, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Penn Medicine, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal for immunotherapy of cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Melanoma; Carcinoma, Renal Cell; Kidney Neoplasms; Ipilimumab; Nivolumab; Immunotherapy; Renal cell carcinoma; Clinical Trials As Topic; Immune Checkpoint Inhibitors
- PubMed ID
- 38604810
- PubMed Central ID
- PMC11015345
- Open access
- Yes, open
- Added to directory
- Source checked